Author:
Wijnhoven B. P. L.,Siersema P. D.,Haustermans Prof. dr. K.,Tilanus Prof. dr. H. W.,Lerut T.
Reference11 articles.
1. Bergman JG. The endoscopic diagnosis and staging of oesophageal adenocarcinoma. Best Pract res Clin Gastroenterol 2006;20(5):843–66.
2. Conroy T, Marchal F, Blazeby JM. Quality of life in patients with oesophageal and gastric cancer: an overview. Oncology 2006;70:391–402.
3. Gebski V, Burmeister B, Smithers BM, et al., Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007;8(3):226–34.
4. Grünberger B, Raderer M, Schmidinger M, Hejna M. Palliative chemotherapy for recurrent and metastatic esophageal cancer. Review. Anticancer Res 2007 Jul-Aug;27(4 C):2705–14.
5. Lagergren J. Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 2006;7(4): 347–9.